Test Price
2,800 AED✅ Home Collection Available
ACTA1 Gene Myopathy with Fiber-Type Disproportion Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 certified processing.
- Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection, available daily 8 AM to 11 PM.
- Post-Test Guidance: Telephone consultation with a qualified genetic specialist to interpret results.
- Insurance: Direct coverage verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ACTA1 Genetic Test provides a definitive molecular diagnosis for congenital myopathy with fibre-type disproportion. Using next-generation sequencing, it covers the entire coding region and splice sites, enabling precise genotyping, family counselling, and personalised treatment planning in the UAE.
| Feature | Our Test (NGS for ACTA1) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | ≥99.9% analytical sensitivity, full gene coverage including deep intronic regions | Limited to known hotspots; may miss rare or deep intronic variants |
| Methodology | Next‑Generation Sequencing (Illumina) + Copy Number Variant detection | Sanger sequencing – point mutations only, no copy number analysis |
| Turnaround Time | 3–4 Weeks (comprehensive bioinformatics) | 4–6 Weeks |
| Clinical Utility | Definitive diagnosis, prenatal/carrier testing ready | Often requires reflex to broader panel, additional cost |
Physician Insight & Safety Protocols
“In my practice, this test transforms the diagnostic journey for families affected by congenital myopathy. A positive result gives clarity; a negative result still leaves room for further investigation with muscle biopsy and broader panels. Always interpret the genetic findings in the context of a full neurological and musculoskeletal evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication and Clinical Context
Do not discontinue prescribed medication without consulting your doctor. This test is an adjunct, not a replacement for clinical judgement.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide informed consent (including minors without legal guardian consent), severe bleeding disorders without medical clearance, acute febrile illness requiring postponement of blood draw.
- Emergency Red Flags: This test is not for acute emergencies. If you or the patient experience sudden severe muscle weakness, breathing difficulty, choking, or cardiac symptoms, proceed immediately to the nearest emergency department.
For pre-test counselling and to review any contraindications, contact our clinical team at +971545488731.
Patient FAQ & Clinical Guidance
1. What is the ACTA1 gene myopathy test and who should consider it?
This genetic test analyzes the entire ACTA1 gene for mutations causing congenital myopathy with fibre-type disproportion, enabling definitive early diagnosis and personalised care. It is recommended for infants and children with hypotonia, motor delay, or muscle weakness, as well as adults with undiagnosed myopathy and a family history of neuromuscular disease.
2. How accurate is the home collection process and what preparation is required?
Our ISO‑certified cold‑chain home collection achieves 99.9% sample integrity, with a simple blood draw that requires no fasting. The only pre‑test requirement is a genetic counselling session to map your family pedigree and review clinical history.
3. What does the 2800 AED cost include and can I use insurance?
The 2800 AED fee covers the full NGS test, pre‑ and post‑test genetic counselling, and a detailed clinical report. We verify insurance coverage directly via WhatsApp (+971 54 548 8731), and many UAE plans recognise this diagnostic when ordered by a neurologist or geneticist.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is processed and stored within HADR‑protected servers inside the UAE. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and DHA Facility License 1143.
Clinical & Logistical Metadata
| Test Name | ACTA1 Gene Myopathy with Fiber-Type Disproportion Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (Illumina) + Copy Number Variant Detection |
| ICD-10-CM Code | G71.2, Z15.89, Z13.89 |
| LOINC Code | 78603-1 |
| DHA Facility License & Laboratory Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians